Found: 17
Select item for more details and to access through your institution.
Pharmacokinetics of fixed-dose combination of atorvastatin and metformin compared with individual tablets.
- Published in:
- Drug Design, Development & Therapy, 2019, v. 13, p. 1623, doi. 10.2147/DDDT.S193254
- By:
- Publication type:
- Article
Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of fimasartan, amlodipine, and rosuvastatin using partial replicated design in healthy adult subjects.
- Published in:
- Drug Design, Development & Therapy, 2018, v. 12, p. 1157, doi. 10.2147/DDDT.S164215
- By:
- Publication type:
- Article
A Randomized, Double-Blind Trial Comparing the Pharmacokinetics of CT-P16, a Candidate Bevacizumab Biosimilar, with its Reference Product in Healthy Adult Males.
- Published in:
- BioDrugs, 2019, v. 33, n. 2, p. 173, doi. 10.1007/s40259-019-00340-x
- By:
- Publication type:
- Article
Population Pharmacokinetic Analysis of Simvastatin and its Active Metabolite with the Characterization of Atypical Complex Absorption Kinetics.
- Published in:
- Pharmaceutical Research, 2014, v. 31, n. 7, p. 1801, doi. 10.1007/s11095-013-1284-0
- By:
- Publication type:
- Article
Effect of Cilostazol on the Pharmacokinetics of Simvastatin in Healthy Subjects.
- Published in:
- BioMed Research International, 2019, p. 1, doi. 10.1155/2019/1365180
- By:
- Publication type:
- Article
Isoniazid Population Pharmacokinetics and Dose Recommendation for Korean Patients With Tuberculosis Based on Target Attainment Analysis.
- Published in:
- Journal of Clinical Pharmacology, 2021, v. 61, n. 12, p. 1567, doi. 10.1002/jcph.1931
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of Tegoprazan Coadministered With Amoxicillin and Clarithromycin in Healthy Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2021, v. 61, n. 7, p. 913, doi. 10.1002/jcph.1805
- By:
- Publication type:
- Article
Physiologically Based Pharmacokinetic Modeling Approach to Predict Drug‐Drug Interactions With Ethionamide Involving Impact of Genetic Polymorphism on FMO3.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 6, p. 880, doi. 10.1002/jcph.1378
- By:
- Publication type:
- Article
Development of a Physiologically Based Pharmacokinetic Model of Ethionamide in the Pediatric Population by Integrating Flavin‐Containing Monooxygenase 3 Maturational Changes Over Time.
- Published in:
- Journal of Clinical Pharmacology, 2018, v. 58, n. 10, p. 1347, doi. 10.1002/jcph.1133
- By:
- Publication type:
- Article
Effects of Renal Impairment on the Pharmacokinetics and Safety of Udenafil.
- Published in:
- Journal of Clinical Pharmacology, 2018, v. 58, n. 7, p. 905, doi. 10.1002/jcph.1095
- By:
- Publication type:
- Article
The pharmacokinetic and pharmacodynamic interaction of clopidogrel and cilostazol in relation to CYP2C19 and CYP3A5 genotypes.
- Published in:
- British Journal of Clinical Pharmacology, 2016, v. 81, n. 2, p. 301, doi. 10.1111/bcp.12794
- By:
- Publication type:
- Article
The effect of Ginkgo biloba extracts on the pharmacokinetics and pharmacodynamics of cilostazol and its active metabolites in healthy Korean subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 77, n. 5, p. 821, doi. 10.1111/bcp.12236
- By:
- Publication type:
- Article
Para‐aminosalicylic acid significantly reduced tenofovir exposure in human subjects: Mismatched findings from in vitro to in vivo translational research.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 3, p. 1159, doi. 10.1111/bcp.15056
- By:
- Publication type:
- Article
Absolute bioavailability and pharmacokinetics of the angiotensin II receptor antagonist fimasartan in healthy subjects.
- Published in:
- Journal of Clinical Pharmacology, 2016, v. 56, n. 5, p. 576, doi. 10.1002/jcph.618
- By:
- Publication type:
- Article
Population plasma and urine pharmacokinetics of ivabradine and its active metabolite S18982 in healthy Korean volunteers.
- Published in:
- Journal of Clinical Pharmacology, 2016, v. 56, n. 4, p. 439, doi. 10.1002/jcph.614
- By:
- Publication type:
- Article
The effect of CYP2C19 genotype on the time course of platelet aggregation inhibition after clopidogrel administration.
- Published in:
- Journal of Clinical Pharmacology, 2014, v. 54, n. 8, p. 850, doi. 10.1002/jcph.225
- By:
- Publication type:
- Article
Pharmacokinetic equivalence of CT‐P17 to high‐concentration (100 mg/ml) reference adalimumab: A randomized phase I study in healthy subjects.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 4, p. 1280, doi. 10.1111/cts.12967
- By:
- Publication type:
- Article